Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2009 1
2011 4
2012 1
2015 5
2016 3
2017 2
2018 5
2019 7
2020 10
2021 11
Text availability
Article attribute
Article type
Publication date

Search Results

43 results
Results by year
Filters applied: . Clear all
Page 1
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes.
Bakris GL, Agarwal R, Anker SD, Pitt B, Ruilope LM, Rossing P, Kolkhof P, Nowack C, Schloemer P, Joseph A, Filippatos G; FIDELIO-DKD Investigators. Bakris GL, et al. N Engl J Med. 2020 Dec 3;383(23):2219-2229. doi: 10.1056/NEJMoa2025845. Epub 2020 Oct 23. N Engl J Med. 2020. PMID: 33264825
Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial.
Bakris GL, Agarwal R, Anker SD, Pitt B, Ruilope LM, Nowack C, Kolkhof P, Ferreira AC, Schloemer P, Filippatos G; on behalf of the FIDELIO-DKD study investigators; FIDELIO-DKD study investigators. Bakris GL, et al. Am J Nephrol. 2019;50(5):333-344. doi: 10.1159/000503713. Epub 2019 Oct 25. Am J Nephrol. 2019. PMID: 31655812 Free PMC article. Clinical Trial.
SGLT2 Inhibitors: Slowing of Chronic Kidney Disease Progression in Type 2 Diabetes.
Wheeler DC, James J, Patel D, Viljoen A, Ali A, Evans M, Fernando K, Hicks D, Milne N, Newland-Jones P, Wilding J; as part of the Improving Diabetes Steering Committee. Wheeler DC, et al. Among authors: patel d. Diabetes Ther. 2020 Dec;11(12):2757-2774. doi: 10.1007/s13300-020-00930-x. Epub 2020 Sep 29. Diabetes Ther. 2020. PMID: 32996085 Free PMC article. Review.
Issues in Geriatric Care: Falls.
Patel D, Ackermann RJ. Patel D, et al. FP Essent. 2018 May;468:18-25. FP Essent. 2018. PMID: 29714993 Review.
Optimising the Benefits of SGLT2 Inhibitors for Type 1 Diabetes.
Evans M, Hicks D, Patel D, Patel V, McEwan P, Dashora U. Evans M, et al. Among authors: patel d. Diabetes Ther. 2020 Jan;11(1):37-52. doi: 10.1007/s13300-019-00728-6. Epub 2019 Dec 7. Diabetes Ther. 2020. PMID: 31813092 Free PMC article. Review.
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial.
Heerspink HJL, Parving HH, Andress DL, Bakris G, Correa-Rotter R, Hou FF, Kitzman DW, Kohan D, Makino H, McMurray JJV, Melnick JZ, Miller MG, Pergola PE, Perkovic V, Tobe S, Yi T, Wigderson M, de Zeeuw D; SONAR Committees and Investigators. Heerspink HJL, et al. Lancet. 2019 May 11;393(10184):1937-1947. doi: 10.1016/S0140-6736(19)30772-X. Epub 2019 Apr 14. Lancet. 2019. PMID: 30995972 Clinical Trial.
Management of diabetes in patients with COVID-19.
Li A, Harris S, Kariyawasam D, Patel DC, Thomas SM. Li A, et al. Among authors: patel dc. Lancet Diabetes Endocrinol. 2020 Aug;8(8):668. doi: 10.1016/S2213-8587(20)30234-5. Lancet Diabetes Endocrinol. 2020. PMID: 32707111 Free PMC article. No abstract available.
SGLT2 Inhibitors: Cardiovascular Benefits Beyond HbA1c-Translating Evidence into Practice.
Ali A, Bain S, Hicks D, Newland Jones P, Patel DC, Evans M, Fernando K, James J, Milne N, Viljoen A, Wilding J; As part of The Improving Diabetes Steering Committee. Ali A, et al. Among authors: patel dc. Diabetes Ther. 2019 Oct;10(5):1595-1622. doi: 10.1007/s13300-019-0657-8. Epub 2019 Jul 9. Diabetes Ther. 2019. PMID: 31290126 Free PMC article. Review.
US Emergency Medical Services Fellows.
Clemency B, Martin-Gill C, Rall N, Patel D, Myers J. Clemency B, et al. Among authors: patel d. Prehosp Disaster Med. 2018 Jun;33(3):339-341. doi: 10.1017/S1049023X18000249. Epub 2018 Apr 18. Prehosp Disaster Med. 2018. PMID: 29667566
43 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page